help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 4, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1645
A more recent version of this article appeared on March 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/3/1150    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blanes, A.
Right arrow Articles by Diaz-Cano, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blanes, A.
Right arrow Articles by Diaz-Cano, S. J.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Medline Plus Health Information
*Pheochromocytoma

Submitted on July 22, 2005
Accepted on December 27, 2005

Topographic Molecular Profile of Pheochromocytomas: Role of Somatic Down-regulation of Mismatch Repair

Alfredo Blanes, Juan J. Sanchez-Carrillo, and Salvador J. Diaz-Cano*

Department of Pathology, University of Malaga School of Medicine, Malaga, Spain; Department of Pathology, King's College Hospital and King's College School of Medicine, London, United Kingdom

* To whom correspondence should be addressed. E-mail: salvador.diaz-cano{at}kcl.ac.uk.

Context and objective: Despite extensive molecular investigation of adrenal pheochromocytomas, no information is available on their molecular and mismatch repair (MMR) profile by topographic compartments.

Design and setting: Microdissected samples from the peripheral and internal zones of 143 pheochromocytomas from a referral Hospital (95 sporadic, 48 associated to MEN-2A) were selected for loss of heterozygosity (LOH) and single nucleotide polymorphism (SNP) analyses. Five polymorphic DNA regions from TP53, RB1, WT1, and NF1 were systematically studied by PCR-denaturing gradient gel electrophoresis.

Patients, outcome measures, and interventions: Pheochromocytomas were classified malignant (16 sporadic tumors with distant metastases), locally invasive (30 sporadic tumors showing retroperitoneal infiltration only), and benign (all remaining tumors). Statistical differences were evaluated using Fisher's exact test. MMR was assessed by MLH1/MSH2 sequencing and immunostaining in PCC with ≥2 abnormal microsatellites. No interventions were done in this study

Results: LOH/SNP involved TP53 in 40/134 informative cases (29.9%), RB1 in 22/106 informative cases (20.8%), WT1 in 32/120 informative cases (26.7%), and NF1 in 32/80 informative cases (40.0%). More genetic abnormalities involving the peripheral compartment were revealed in 34 pheochromocytomas (23.8%): 12/16 malignant, 10/30 locally invasive, and 12/97 benign. Multiple and coexistent genetic abnormalities characterized malignant pheochromocytomas (P < 0.001), whereas locally invasive pheochromocytomas showed significantly higher incidence of NF1 alterations (P < 0.001). No mutations were identified in MLH1/MSH2 but MMR proteins significantly decreased in peripheral compartments.

Conclusions: Multiple microsatellite alterations and topographic intratumor heterogeneity characterize malignant pheochromocytomas, suggesting a multistep tumorigenesis through somatic topographic down-regulation of MMR proteins. Locally invasive pheochromocytomas reveal topographic heterogeneity and single locus microsatellite alterations, especially involving NF1.


Key words: Multiple Endocrine Neoplasia 2A • Tumor Suppressor Gene • Loss of Heterozygosity • Single Nucleotide Polymorphism • Tumor Heterogeneity







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society